Patient-reported health-related quality of life from the phase III TOURMALINE-MM1 study of ixazomib-lenalidomide-dexamethasone versus placebo-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma.

Leleu, Xavier; Masszi, Tamas; Bahlis, Nizar J; Viterbo, Luisa; Baker, Bartrum; Gimsing, Peter; Maisnar, Vladimir; Samoilova, Olga; Rosiñol, Laura; Langer, Christian; Song, Kevin; Izumi, Tohru; Cleeland, Charles; Berg, Deborah; Lin, Huamao Mark; Zhu, Yanyan; Skacel, Tomas; Moreau, Philippe; Richardson, Paul G

Leleu, Xavier; Masszi, Tamas; Bahlis, Nizar J; Viterbo, Luisa; Baker, Bartrum; Gimsing, Peter; Maisnar, Vladimir; Samoilova, Olga; Rosiñol, Laura; Langer, Christian; Song, Kevin; Izumi, Tohru; Cleeland, Charles; Berg, Deborah; Lin, Huamao Mark; Zhu, Yanyan; Skacel, Tomas; Moreau, Philippe; Richardson, Paul G.

Afiliação

Leleu X; Department of Haematology, Hospital La Milétrie, and INSERM CIC 1402, Poitiers, France.
Masszi T; Department of Hematology and Stem Cell Transplantation, St. István and St. László Hospital, 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
Bahlis NJ; Southern Alberta Cancer Research Institute, University of Calgary, Calgary, Alberta, Canada.
Viterbo L; Serviço de Onco-Hematologia, Instituto Português de Oncologia do Porto Francisco Gentil, Entidade Pública Empresarial (IPOPFG, EPE), Porto, Portugal.
Baker B; Department of Haematology, Palmerston North Hospital, Palmerston North, Manawatu, New Zealand.
Gimsing P; Department of Hematology, University Hospital Rigshospitalet, Copenhagen, Denmark.
Maisnar V; 4th Department of Medicine - Hematology, University Hospital, Hradec Kralove, Czech Republic.
Samoilova O; Nizhnii Novgorod Region Clinical Hospital, Nizhnii Novgorod, Russia.
Rosiñol L; Department of Hematology, University of Barcelona, Barcelona, Spain.
Langer C; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany.
Song K; Division of Hematology, University of British Columbia, Vancouver, Canada.
Izumi T; Department of Hematology, Tochigi Cancer Center, Utsunomiya, Tochigi, Japan.
Cleeland C; Department of Symptom Research, University of Texas M.D. Anderson Cancer Center, Houston, Texas.
Berg D; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
Lin HM; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
Zhu Y; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
Skacel T; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
Moreau P; Department of Hematology, Charles University General Hospital, Prague, Czech Republic.
Richardson PG; Department of Hematology, University Hospital Hôtel Dieu, Nantes, France.

Am J Hematol ; 2018 May 04.

Article em En | MEDLINE | ID: mdl-29726031

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Am J Hematol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google